Yesterday, Sept. 16, 2015, 72 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.69 to $4,488,945.00.

Highlighted Stocks Traded by Insiders:

Village Super Market (VLGEA) - FREE Research Report

Estate of Perry Sumas, who is Shareholder at Village Super Market, sold 3,500 shares at $26.46 on Sept. 16, 2015. Following this transaction, the Shareholder owned 844,953 shares meaning that the stake was reduced by 0.41% with the 3,500-share transaction.

The shares most recently traded at $27.42, up $0.96, or 3.51% since the insider transaction. Historical insider transactions for Village Super Market go as follows:

  • 4-Week # shares sold: 49,458
  • 12-Week # shares sold: 87,212
  • 24-Week # shares sold: 239,749

The average volume for Village Super Market has been 23,900 shares per day over the past 30 days. Village Super Market has a market cap of $257.1 million and is part of the services sector and retail industry. Shares are down 0.69% year-to-date as of the close of trading on Wednesday.

Village Super Market, Inc., together with its subsidiaries, operates a chain of supermarkets in the United States. The stock currently has a dividend yield of 3.81%. The company has a P/E ratio of 12.5. Currently, there are no analysts who rate Village Super Market a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VLGEA - FREE

TheStreet Quant Ratings rates Village Super Market as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, compelling growth in net income, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Village Super Market Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ImmuCell (ICCC) - FREE Research Report

Wainman Paul R, who is Director at ImmuCell, bought 175 shares at $6.80 on Sept. 16, 2015. Following this transaction, the Director owned 2,000 shares meaning that the stake was boosted by 9.59% with the 175-share transaction.

The shares most recently traded at $6.69, down $0.11, or 1.64% since the insider transaction. Historical insider transactions for ImmuCell go as follows:

  • 4-Week # shares bought: 11,600
  • 12-Week # shares bought: 11,600
  • 24-Week # shares bought: 11,600

The average volume for ImmuCell has been 19,700 shares per day over the past 30 days. ImmuCell has a market cap of $20.1 million and is part of the health care sector and drugs industry. Shares are up 34.36% year-to-date as of the close of trading on Wednesday.

ImmuCell Corporation develops, acquires, manufactures, and sells products that enhance animal health and productivity in the dairy and beef industries in the United States and internationally. The company has a P/E ratio of 29.9.

Exclusive Offer: Get the latest Stock Analysis on ICCC - FREE

TheStreet Quant Ratings rates ImmuCell as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full ImmuCell Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Everi Holdings (EVRI) - FREE Research Report

Kilburn E Miles, who is Director at Everi Holdings, bought 10,000 shares at $4.97 on Sept. 16, 2015. Following this transaction, the Director owned 157,645 shares meaning that the stake was boosted by 6.77% with the 10,000-share transaction.

The shares most recently traded at $5.24, up $0.27, or 5.15% since the insider transaction. Historical insider transactions for Everi Holdings go as follows:

  • 4-Week # shares bought: 9,000
  • 12-Week # shares bought: 174,000
  • 24-Week # shares bought: 174,000

The average volume for Everi Holdings has been 626,100 shares per day over the past 30 days. Everi Holdings has a market cap of $332.3 million and is part of the services sector and leisure industry. Shares are down 26.71% year-to-date as of the close of trading on Wednesday.

Everi Holdings Inc. provides cash access services and related equipment and services to the gaming industry. The company operates in Cash Advance, ATM, Check Services, Games, and Other segments. Currently, there are 4 analysts who rate Everi Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on EVRI - FREE

TheStreet Quant Ratings rates Everi Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Everi Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.